The DOI matches its Crossref record.
New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans
Abstract
Abstract: A collaborative study involving a large sample of European Americans was typed for the histocompatibility loci of the HLA DR‐DQ region and subjected to intensive typing validation measures in order to accurately determine haplotype composition and frequency. The resulting tables have immediate application to HLA typing and allogeneic transplantation. The loci within the DR‐DQ region are especially valuable for such an undertaking because of their tight linkage and high linkage disequilibrium. The 3798 haplotypes, derived from 1899 unrelated individuals, had a total of 75 distinct DRB1‐DQA1‐DQB1 haplotypes. The frequency distribution of the haplotypes was right skewed with haplotypes occurring at a frequency of less than 1% numbering 59 and yet constituting less than 12% of the total sample. Given DRB1 typing, it was possible to infer the exact DQA1 and DQB1 composition of a haplotype with high confidence (>90% likelihood) in 21 of the 35 high‐resolution DRB1 alleles present in the sample. Of the DRB1 alleles without high reliability for DQ haplotype inference, only *0401, *0701 and *1302 were common, the remaining 11 DRB1 alleles constituting less than 5% of the total sample. This approach failed for the 13 serologically equivalent DR alleles in which only 33% of DQ haplotypes could be reliably inferred. The 36 DQA1‐DQB1 haplotypes present in the total sample conformed to the known pattern of permissible heterodimers. Four DQA1‐DQB1 haplotypes, all rare, are reported here for the first time. The haplotype frequency tables are suitable as a reference standard for HLA typing of the DR and DQ loci in European Americans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, HLA-DQ6 was overrepresented within our small NMOSD cohort (9 out of 22 typed samples [41%] versus 15%-20% in Europe 57,58 ; Table S5).”
From Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases (2024) · cites this paper as [58]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 21
- 10.1038/sj.bmt.1702161 · DOI
- Bignon JD, 1997, Proceedings of the 12th International Histocompatibility Workshop and Conference, 1
- 10.1016/0198-8859(94)90043-4 · DOI
- 10.1111/j.1399-0039.1992.tb01940.x · DOI
- 10.1111/j.1399-0039.1993.tb01991.x · DOI
- Kalman LV, 1995, Thermostable DNA polymerase with altered discrimination properties, Genome Sci Technol, 1, 42
- 10.1016/S1084-8592(96)70024-3 · DOI
- Long JC, 1995, An E‐M algorithm and testing strategy for multiple‐locus haplotypes, Am J Hum Genet, 56, 799
- Baur MP, Histocompatibility Testing 1980.
- 10.1046/j.1365-2540.2001.00966.x · DOI
- 10.1111/j.1399-0039.1997.tb02801.x · DOI
- 10.1111/j.1399-0039.1991.tb01904.x · DOI
- 10.1016/0198-8859(93)90504-T · DOI
- 10.1016/S0198-8859(01)00212-9 · DOI
- Nepom BS, 1987, Transcomplementation of HLA genes in IDDM. HLA‐DQ a and b‐cahins produce hybrid molecules in DR3/4 heterozygotes, Diabetes, 36, 114, 10.2337/diab.36.1.114 · DOI
- Kwok WW, 1993, HLA‐DQ allelic polymorphisms constrain patterns of class II heterodimer formation, J Immunol, 50, 2263, 10.4049/jimmunol.150.6.2263 · DOI
- 10.1086/342973 · DOI
- Begovich AB, 1991, : Recombination, polymorphism and disequilibrium across the HLA class II region, J Immunol, 148, 249, 10.4049/jimmunol.148.1.249 · DOI
- 10.1016/0198-8859(94)90041-8 · DOI
- PosthumaEF FalkenburgJH ApperleyJFet al.HLA‐DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant Registry.Leukemia2001:192–3. · DOI
- 10.1007/978-4-431-65868-9_31 · DOI
Cited by
Sorted by citations
The Journal of Clinical Investigation
Witkin, E. M. (2016) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(94)92394-9 · Cited by 920
High-resolution HLA alleles and haplotypes in the United States population
Maiers, M. J., Gragert, L. A., & Klitz, W. (2007) · Human Immunology · doi:10.1016/j.humimm.2007.04.005 · Cited by 456
“The donor–recipient pair donor typing was subjected to a rigorous quality control program as previously described [ 3 ].”
MethodSelf-citationSolberg, O. D., Mack, S. J., Lancaster, A. K., Single, R. M., Tsai, Y., Sanchez‐Mazas, A., & Thomson, G. J. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.05.001 · Cited by 345
Amico, P., Hönger, G., Mayr, M., Steiger, J., Hopfer, H., & Schaub, S. (2009) · Transplantation · doi:10.1097/tp.0b013e3181a5e034 · Cited by 271
“HLA-DQ antigens were primarily inferred from the HLA-DR antigens, which are in strong linkage disequilibrium (12).”
BackgroundRheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy
Alam, J., Jantan, I., & Bukhari, S. N. A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.055 · Cited by 286
Common and Well-Documented HLA Alleles: 2012 Update to the CWD Catalogue
Mack, S., Cano, P., Hollenbach, J., He, J., Hurley, C. K., Middleton, D., Moraes, M., Pereira, S., Kempenich, J., Reed, E., et al. (2013) · Tissue Antigens · doi:10.1111/tan.12093 · Cited by 235
Self-citationCano, P., Klitz, W., Mack, S., Maiers, M., Marsh, S. G., Noreen, H., Reed, E., Senitzer, D., Setterholm, M., Smith, A. G., et al. (2007) · Human Immunology · doi:10.1016/j.humimm.2007.01.014 · Cited by 229
Self-citationDuquesnoy, R., & Askar, M. (2007) · Human Immunology · doi:10.1016/j.humimm.2006.10.003 · Cited by 225
Steere, A., Klitz, W., Drouin, E. E., Falk, B., Kwok, W., Nepom, G., & Lee, A. B.-L. (2006) · Journal of Experimental Medicine · doi:10.1084/jem.20052471 · Cited by 207
“The 42 rare haplotypes that were found only in the control population are not shown here, but a complete listing of haplotypes in the control population has been published previously (19).”
BackgroundSelf-citationCiurea, S. O., Thall, P. F., Wang, X., Wang, S. A., Hu, Y., Cano, P., Aung, F. M., Rondón, G., Molldrem, J. J., Korbling, M. J., et al. (2011) · Blood · doi:10.1182/blood-2011-06-362111 · Cited by 230
“In the present study DPA1 and DQA1 were not typed; possible DSA against alleles of these loci were examined by inferring the alleles likely to be present at these loci from the tight associations with alleles at the contiguous DPB1 and DRB1/DQB1 loci, respectively.(12,13) No transplants were performed in patients pres…”
BackgroundFine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease
Gutierrez‐Achury, J., Zhernakova, A., Pulit, S. L., Trynka, G., Hunt, K. A., Romanos, J., Raychaudhuri, S., van Heel, D. A., Wijmenga, C., & de Bakker, P. I. W. (2015) · Nature Genetics · doi:10.1038/ng.3268 · Cited by 154
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32
Conde, L., Halperin, E., Akers, N. K., Brown, K. M., Smedby, K. E. E., Rothman, N., Nieters, A., Slager, S. L., Brooks-Wilson, A. R., Agana, L., et al. (2010) · Nature Genetics · doi:10.1038/ng.626 · Cited by 158
Fernández-Viña, M., Klein, J., Haagenson, M., Spellman, S., Anasetti, C., Noreen, H., Lee, A. B.-L., Cano, P., Flomenberg, N., Confer, D., et al. (2013) · Blood · doi:10.1182/blood-2013-02-481945 · Cited by 155
“Donor age, median (range), y 36 (18-60) 36 (19-59) 36 (18-60) .”
InfluentialSelf-citationHLA‐DR and ‐DQ Eplet Mismatches and Transplant Glomerulopathy: A Nested Case–Control Study
Sapir-Pichhadze, R., Tinckam, K., Quach, K., Logan, A., Laupacis, A., John, R., Beyene, J., & Kim, S. (2015) · American Journal of Transplantation · doi:10.1111/ajt.12968 · Cited by 128
Keller, M. D., Harris, K. M., Jensen-Wachspress, M. A., Kankate, V. V., Lang, H., Lazarski, C. A., Durkee-Shock, J. R., Lee, P., Chaudhry, K., Webber, K., et al. (2020) · Blood · doi:10.1182/blood.2020008488 · Cited by 126
Mapping of Immune-Mediated Disease Genes
Ricaño-Ponce, I., & Wijmenga, C. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153450 · Cited by 121
Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies
OʼHanlon, T. P., Carrick, D. M., Arnett, F. C., Reveille, J. D., Carrington, M. N., Gao, X., Oddis, C. V., Morel, P. A., Malley, J. D., Malley, K. G., et al. (2005) · Medicine · doi:10.1097/01.md.0000189818.63141.8c · Cited by 102
Scully, M., Brown, J., Patel, R., Mcdonald, V., Brown, C., & Machin, S. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03692.x · Cited by 100
Duquesnoy, R., Awadalla, Y., Lomago, J., Jelinek, L., Howe, J., Zern, D., Hunter, B., Martell, J., Girnita, A., & Zeevi, A. (2008) · Transplant Immunology · doi:10.1016/j.trim.2007.10.001 · Cited by 94
Ancient DNA study reveals HLA susceptibility locus for leprosy in medieval Europeans
Krause‐Kyora, B., Nutsua, M., Boehme, L., Pierini, F., Pedersen, D. D., Kornell, S.-C., Drichel, D., Bonazzi, M., Möbus, L., Tarp, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03857-x · Cited by 104
Risk stratification by the virtual crossmatch: a prospective study in 233 renal transplantations
Amico, P., Hirt-Minkowski, P., Hönger, G., Gürke, L., Mihatsch, M., Steiger, J., Hopfer, H., & Schaub, S. (2011) · Transplant International · doi:10.1111/j.1432-2277.2011.01235.x · Cited by 90
“In 32/132 deceased donors (24%), HLA-DQb antigens were not determined but inferred from the HLA-DRb antigens, which are in strong linkage disequilibrium [16].”
BackgroundStepniak, D., Wiesner, M., de Ru, A. H., Moustakas, A., Drijfhout, J., Papadopoulos, G., van Veelen, P. V., & Koning, F. (2008) · Journal of Immunology · doi:10.4049/jimmunol.180.5.3268 · Cited by 90
“The association of HLA-DQ2 with CD is extraordinarily strong: approximately 95% of CD patients carry the DQ2 phenotype wheraes in general population the frequency of this allele is about 2030% [4,5].”
Tambur, A., Leventhal, J. R., Friedewald, J., & Ramon, D. S. (2010) · Transplantation · doi:10.1097/tp.0b013e3181f89c6d · Cited by 87
Clinical link between MHC class II haplotype and interferon-beta (IFN-β) immunogenicity
Barbosa, M. D. F. S., Vielmetter, J., Chu, S. Y., Smith, D. D., & Jacinto, J. M. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.08.017 · Cited by 99
Lee, E. H., Lendas, K. A., Chow, S., Pirani, Y., Gordon, D., Dionisio, R. G., Nguyen, D., Spizuoco, A., Fotino, M., Zhang, Y., et al. (2006) · Human Immunology · doi:10.1016/j.humimm.2005.09.003 · Cited by 83
Anand, V., Li, Y., Liu, B., Ghalwash, M., Koski, E., Ng, K., Dunne, J. L., Jönsson, J., Winkler, C., Knip, M., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1836 · Cited by 83
Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA
Miyadera, H., Ohashi, J., Lernmark, Å., Kitamura, T., & Tokunaga, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74961 · Cited by 86
Utility of genetic risk scores in type 1 diabetes
Luckett, A. M., Weedon, M. N., Hawkes, G., Leslie, R. D., Oram, R. A., & Grant, S. F. A. (2023) · Diabetologia · doi:10.1007/s00125-023-05955-y · Cited by 80
Saggau, C., Bacher, P., Esser, D., Rasa, M., Meise, S., Mohr, N., Kohlstedt, N., Hutloff, A., Schacht, S.-S., Dargvainiene, J., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.08.005 · Cited by 79
Bächler, K., Amico, P., Hönger, G., Bielmann, D., Hopfer, H., Mihatsch, M., Steiger, J., & Schaub, S. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03093.x · Cited by 73
“antigens, which are in strong linkage disequilibrium (14).”
BackgroundThe probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable
Tiercy, J.-M., Nicoloso, G., Passweg, J. R., Schanz, U., Seger, R. A., Chalandon, Y., Heim, D. A., Güngör, T., Schneider, P., Schwabe, R., et al. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705787 · Cited by 65
Mack, S. J., Tu, B., Lázaro, A., Yang, R., Lancaster, A. K., Cao, K., Ng, J., & Hurley, C. K. (2008) · Tissue Antigens · doi:10.1111/j.1399-0039.2008.01151.x · Cited by 73
Levy, H., Wang, X., Kaldunski, M. L., Jia, S., Kramer, J., Pavletich, S. J., Reske, M., Gessel, T., Yassai, M. B., Quasney, M. W., et al. (2012) · Genes and Immunity · doi:10.1038/gene.2012.41 · Cited by 72
Malheiro, J., Tafulo, S., Dias, L., Martins, L., Fonseca, I., Beirão, I., Castro-henriques, A., & Cabrita, A. (2015) · Transplant Immunology · doi:10.1016/j.trim.2015.01.002 · Cited by 67
Molecular Signatures Differentiate Immune States in Type 1 Diabetic Families
Chen, Y.-G., Cabrera, S. M., Jia, S., Kaldunski, M., Kramer, J., Cheong, S., Geoffrey, R., Roethle, M. F., Woodliff, J., Greenbaum, C., et al. (2014) · Diabetes · doi:10.2337/db14-0214 · Cited by 65
“Subjects were genotyped for HLA-DQB1 and haplotypes were inferred using Caucasian haplotype frequencies as described (24,28).”
MethodJin, Y., Roberts, G., Ferrara, T., Ben, S., van Geel, N., Wolkerstorfer, A., Ezzedine, K., Siebert, J., Neff, C., Palmer, B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08337-4 · Cited by 64
New reservoirs of HLA alleles: pools of rare variants enhance immune defense
Klitz, W., Hedrick, P. W., & Louis, E. J. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.06.007 · Cited by 66
Self-citationSnanoudj, R., Kamar, N., Cassuto, É., Caillard, S., Metzger, M., Merville, P., Thierry, A., Jollet, I., Grimbert, P., Anglicheau, D., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.12.029 · Cited by 61
Donor‐Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients
Levitsky, J., Kaneku, H., Jie, C.-F., Walsh, R., Abecassis, M., & Tambur, A. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13757 · Cited by 60
“linkage disequilibrium and haplotype frequencies based on ethnicity, as provided by the National Marrow Donor Program (16,17).”
MethodA combined DPA1∼DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer
Hollenbach, J., Madbouly, A., Gragert, L., Vierra-Green, C., Flesch, S., Spellman, S., Begovich, A., Noreen, H., Trachtenberg, E., Williams, T., et al. (2012) · Immunogenetics · doi:10.1007/s00251-012-0615-3 · Cited by 59
“While the allele frequency distributions for DPA1 and DPB1 do not differ significantly from neutral expectations, the frequencies for the broad serological types DP1–DP4 are significantly more even than expected under neutrality, suggesting evidence for balancing selection for these specificities.”
BackgroundMethodInfluentialSelf-citationThe HLA Class II Allele DRB1*1501 Is Over-Represented in Patients with Idiopathic Pulmonary Fibrosis
Xue, J., Gochuico, B. R., Alawad, A. S., Feghali‐Bostwick, C. A., Noth, I., Nathan, S. D., Rosen, G., Rosas, I. O., Đačić, S., Ocak, İ., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014715 · Cited by 58
“Analyses are restricted to Caucasian subjects because ,5% of lung transplantation recipients in the discovery cohort were members of minority groups, and HLA allele frequencies can vary greatly among racial/ethnic subpopulations [29,30].”
BackgroundResultFain, P., Babu, S., Bennett, D., & Spritz, R. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2005.00279.x · Cited by 59
Heaney, A. P., Sumerel, B., Rajalingam, R., Bergsneider, M., Yong, W. H., & Liau, L. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2702 · Cited by 64
“5% of white control subjects (including Hispanic groups) from a very large dataset of bone marrow transplant donors carry the DQ8 or DR53 haplotype (26).”
BackgroundWang, C., Tang, J.-M., Geisler, W., Crowley-Nowick, P., Wilson, C. M., & Kaslow, R. (2005) · Journal of Infectious Diseases · doi:10.1086/428592 · Cited by 57
Levine, A. P., Chan, M., Sadeghi‐Alavijeh, O., Wong, E. K. S., Cook, H. T., Ashford, S. E., Carss, K., Christian, M. T., Hall, M., Harris, C. L., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019040433 · Cited by 65
Advances in HLA: practical implications for selecting adult donors and cord blood units.
Hurley, C., Wagner, J., Setterholm, M., & Confer, D. (2006) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2005.10.005 · Cited by 52
Landscape and Selection of Vaccine Epitopes in SARS-CoV-2Preprint
Smith, C. C., Entwistle, S., Willis, C., Vensko, S. P., Beck, W., Garness, J. A., Sambade, M., Routh, E. D., Olsen, K. S., Kodysh, J., et al. (2020) · bioRxiv · doi:10.1101/2020.06.04.135004 · Cited by 51
Tang, J.-M., Shao, W., Dorak, M., Li, Y.-F., Miike, R., Lobashevsky, E. S., Wiencke, J., Wrensch, M., Kaslow, R., & Cobbs, C. (2005) · Cancer Epidemiology, Biomarkers and Prevention · doi:10.1158/1055-9965.epi-05-0136 · Cited by 50
Vianna, R., Secco, D., Hanhoerderster, L., Motta, J., Cardoso, J., & Pôrto, L. C. (2020) · HLA · doi:10.1111/tan.13940 · Cited by 48
Bestard, O., Meneghini, M., Crespo, E., Bemelman, F., Koch, M., Volk, H., Viklicky, O., Giral, M., Banas, B., Ruiz, J., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16563 · Cited by 47
Butler, M. O., Ansén, S., Tanaka, M., Imataki, O., Berezovskaya, A., Mooney, M. M., Metzler, G., Milstein, M. I., Nadler, L. M., & Hirano, N. (2010) · International Immunology · doi:10.1093/intimm/dxq440 · Cited by 43
Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes
Ostrov, D. A., Alkanani, A. K., McDaniel, K. A., Case, S. R., Baschal, E. E., Pyle, L. L., Ellis, S., Pöllinger, B., Seidl, K. J., Shah, V. N., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97739 · Cited by 54
Hurley, C., Fernández-Viña, M., Hildebrand, W., Noreen, H., Trachtenberg, E., Williams, T., Lee, A. B.-L., Begovich, A., Petersdorf, E., Selvakumar, A., et al. (2007) · Human Immunology · doi:10.1016/j.humimm.2006.09.004 · Cited by 44
Self-citationMikk, M.-L., Kiviniemi, M., Laine, A., Härkönen, T., Veijola, R., Simell, O., Knip, M., & Ilonen, J. (2014) · Human Immunology · doi:10.1016/j.humimm.2013.09.008 · Cited by 43
cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator
Tinckam, K., Liwski, R., Pochinco, D., Mousseau, M., Grattan, A., Nickerson, P., & Campbell, P. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13355 · Cited by 42
Correlation of sensitizing capacity and T-cell recognition within the Bet v 1 family
Kitzmüller, C., Zulehner, N., Roulias, A., Briza, P., Ferreira, F., Faé, I., Fischer, G., & Bohle, B. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.1928 · Cited by 38
Yamamoto, H., Uchida, N., Matsuno, N., Ota, H., Kageyama, K., Wada, S., Kaji, D., Nishida, A., Ishiwata, K., Takagi, S., et al. (2014) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2014.06.024 · Cited by 37
Geisler, W., Tang, J.-M., Wang, C., Wilson, C. M., & Kaslow, R. (2004) · Journal of Infectious Diseases · doi:10.1086/425077 · Cited by 37
“50 ican adolescents ( , including 100 Hispanic and 44 Eun p 145 ropean Americans) in our study, the frequencies of A*23 differed ( ) from those seen elsewhere [25, 27, 28], whereas P .”
BackgroundResultImmune Mechanisms and Pathways Targeted in Type 1 Diabetes
Jacobsen, L. M., Newby, B. N., Perry, D. J., Posgai, A. L., Haller, M. J., & Brusko, T. M. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1066-5 · Cited by 42
Bodd, M., Tollefsen, S., Bergseng, E., Lundin, K., & Sollid, L. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.01.016 · Cited by 35
Multi-locus HLA class I and II allele and haplotype associations with follicular lymphoma
Skibola, C., Akers, N. K., Conde, L., Ladner, M., Hawbecker, S., Cohen, F., Ribas, F., Erlich, H. A., Goodridge, D., Trachtenberg, E. A., et al. (2012) · Tissue Antigens · doi:10.1111/j.1399-0039.2012.01845.x · Cited by 35
Nguyen, H. T. D., Wong, G., Chapman, J., McDonald, S., Coates, P., Watson, N., Russ, G., D'Orsogna, L., & Lim, W. (2016) · Transplantation Direct · doi:10.1097/txd.0000000000000632 · Cited by 34
“However, the lack of acuity for all HLA-DR-DQ haplotypes introduces uncertainties.(28) Our study has focussed only on the risk of early acute rejection within 12 months.”
BackgroundHLA-DQ Barrier: Effects on cPRA Calculations
Tambur, A., Leventhal, J., Walsh, R., Zitzner, J. R., & Friedewald, J. (2013) · Transplantation · doi:10.1097/tp.0b013e3182a452a5 · Cited by 31
“(16), studying a large sample of European American subjects, demonstrated that there is strong linkage disequilibrium between the DQA1 and DQB1 loci in this homogenous Caucasian population.”
BackgroundZhu, W.-H., Lu, J.-H., Lin, J., Xi, J., Lu, J., Luo, S.-S., Qiao, K., Xiao, B.-G., Lu, C.-Z., & Zhao, C. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.03.018 · Cited by 31
“16%) (Klitz et al., 2003; Trachtenberg et al., 2007).”
The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet
McAllister, C. S., & Kagnoff, M. F. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0318-8 · Cited by 32
Klinker, M. W., Schiller, J. J., Magnuson, V. L., Wang, T., Basken, J., Veth, K. N., Pearce, K. I., Kinnunen, L., Harjutsalo, V., Wang, X., et al. (2009) · Immunogenetics · doi:10.1007/s00251-009-0417-4 · Cited by 28
“HLA-DQA1-DQB1 haplotypes (HLA-DQ) and 4-digit resolution of HLA-DQA1 were then inferred using reported European Caucasian haplotype frequencies ( Klitz et al. 2003 ), and confirmed by the E-M algorithm.”
MethodRuiter, B., Rozemuller, E., van Dijk, A. V., Garssen, J., Bruijnzeel-koomen, C., Tilanus, M., Knol, E., & van Hoffen, E. (2007) · International Archives of Allergy and Immunology · doi:10.1159/000098660 · Cited by 28
Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset
Golden, G. J., Wu, V. H., Hamilton, J. T., Amses, K. R., Shapiro, M. R., Japp, A. S., Liu, C., Pampena, M. B., Kuri-Cervantes, L., Knox, J. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59626-0 · Cited by 27
“Phasing of HLA-DQA1 and HLA-DQB1 genotypes was inferred via comparison with published haplotype frequencies from European Americans 104 .”
Malheiro, J., Martins, L., Tafulo, S., Dias, L., Fonseca, I., Beirão, I., Castro-henriques, A., & Cabrita, A. (2016) · Transplant International · doi:10.1111/tri.12687 · Cited by 27
“The loci within the DR-DQ region present a tight linkage and high linkage disequilibrium as shown by a study done in a population with European ancestry [23].”
BackgroundMack, S. J., Tu, B., Yang, R., Masaberg, C., Ng, J., & Hurley, C. K. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.10.017 · Cited by 24
Hou, L., Vierra-Green, C., Lazaro, A. M., Brady, C., Haagenson, M., Spellman, S., & Hurley, C. K. (2016) · HLA · doi:10.1111/tan.12942 · Cited by 25
“Although HLA-DQA1 was not typed at the time of transplant, the tight linkage between HLA-DQA1 and -DQB1 predicts that, if HLA-DQB1 is matched, HLA-DQA1 will also be matched (24).”
BackgroundSelf-citationDhib-Jalbut, S. S., Valenzuela, R. M., Ito, K., Kaufman, M., Picone, M. A., & Buyske, S. G. (2013) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2013.02.005 · Cited by 27
van Autreve, J. V., Weets, I., Gulbis, B., Vertongen, F., Gorus, F., & der Auwera, B. J. V. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.04.004 · Cited by 24
Gragert, L., Spellman, S. M., Shaw, B., & Maiers, M. (2022) · medRxiv · doi:10.1101/2022.11.14.22282311 · Cited by 23
Self-citationFailed Genetic Protection: Type 1 Diabetes in the Presence of HLA-DQB1*06:02
Simmons, K. M., Mitchell, A. M., Alkanani, A. K., McDaniel, K. A., Baschal, E. E., Armstrong, T., Pyle, L. L., Yu, L., & Michels, A. W. (2020) · Diabetes · doi:10.2337/db20-0038 · Cited by 27
Hirv, K., Bloch, K. E., Fischer, M. D., Einsiedler, B., Schrezenmeier, H., & Mytilineos, J. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.53 · Cited by 23
Sinkovits, G., Szilágyi, Á., Farkas, P., Inotai, D., Szilvási, A., Tordai, A., Rázsó, K., Réti, M., & Prohászka, Z. (2017) · Human Immunology · doi:10.1016/j.humimm.2016.11.005 · Cited by 22
Deitiker, P., Oshima, M., Smith, R. G., Mosier, D. R., & Atassi, M. (2011) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2010.00979.x · Cited by 22
“allele or haplotype based on a control data set (Klitz et al., 2003), and is a measure of significant deviations in the higher direction.”
BackgroundMethodInfluentialLiu, B., Deng, T., Zhu, L., & Zhong, J.-X. (2018) · Medicine · doi:10.1097/md.0000000000009914 · Cited by 21
Human genetic variation studies and HLA class II loci
Agrawal, S., Khan, F., & Bharadwaj, U. (2007) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2007.00683.x · Cited by 16
“Frequency of DRB1*0301DQA1*0501-DQB1*0201 is found as high as 11% among Iranis and 12.7% and 13.4%, respectively, among English and American Caucasians (Klitz et al., 2003).”
BackgroundInfluentialFull-resolution HLA and KIR gene annotations for human genome assembliesPreprint
Zhou, Y., Song, L., & Li, H. (2024) · Genome Research · doi:10.1101/gr.278985.124 · Cited by 25
“The HLA class II region is highly structured (Klitz et al. 2003; Norman et al. 2017; Chin et al. 2023), which is commonly characterized by DR haplotype.”
A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human Cytomegalovirus
Ameres, S., Liang, X.-L., Wiesner, M., Mautner, J., & Moosmann, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00598 · Cited by 20
“However, DRB1*0701 is in linkage disequilibrium with DQA1*0201/DQB1*0202 as described (32), and thus carriers of this haplotype can instead target IE-1 through HLA-DQ-restricted CD4 T cells, as seen for two of our three donors with this haplotype (Table 1; Figure 3B).”
BackgroundTorres, I., Salcedo, M., Moreso, F., Sellarés, J., Castellá, E., Azancot, M., Perelló, M., Cantarell, C., & Serón, D. (2014) · Clinical Transplantation · doi:10.1111/ctr.12433 · Cited by 20
“In patients with positive HLA-DQ, the presence/ absence of DSA was assigned according to linkage disequilibrium for DR-DQ types (20).”
MethodMeyer-Monard, S., Passweg, J. R., Troeger, C., Eberhard, H., Roosnek, E., de Faveri, G. N., Chalandon, Y., Rovó, A., Kindler, V., Irion, O., et al. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.391 · Cited by 20
HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
Varga, M., Rajczy, K., Telkes, G., Hídvégi, M., Péter, A., Remport, Á., Korbonits, M., Fazakas, J., Toronyi, É., Sárváry, E., et al. (2008) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfn111 · Cited by 18
“Since HLA-DQ3 has strong linkage disequilibrium with HLA-DR11 [ 13 ], we analysed the data concerning HLA-DR11 in complex with HLA-DQ3.”
BackgroundKauppinen, A., Peräsaari, J. P., Taivainen, A., Kinnunen, T., Saarelainen, S. A., Rytkönen-Nissinen, M., Jeal, H., Jones, M. G., & Virtanen, T. (2012) · Immunobiology · doi:10.1016/j.imbio.2011.08.012 · Cited by 18
Lim, W. C., Costa, M. E. M. D., Godefroy, K., Jacquet, E., Gragert, L. A., Rondof, W., Marchais, A., Nhiri, N., Dalfovo, D., Viard, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1265469 · Cited by 17
Thomas, N. J., Dennis, J., Sharp, S. A., Kaur, A., Misra, S., Walkey, H. C., Johnston, D. G., Oliver, N. S., Hagopian, W., Weedon, M. N., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05513-4 · Cited by 19
Choung, R., Mills, J., Snyder, M., Murray, J., & Gandhi, M. (2020) · Human Immunology · doi:10.1016/j.humimm.2020.01.006 · Cited by 17
HLA-DR-DQ haplotypes and type 1 diabetes in Macedonia.
Ilonen, J., Kocova, M., Lipponen, K., Sukarova-Angelovska, E., Jovanovska, A., & Knip, M. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.03.014 · Cited by 17
Genetic association of HLA DQB1 with CD4+CD25+high T-cell apoptosis in type 1 diabetes
Glišić, S., Klinker, M. W., Waukau, J., Jailwala, P., Jana, S., Basken, J., Wang, T., Alemzadeh, R., Hagopian, W., & Ghosh, S. (2009) · Genes and Immunity · doi:10.1038/gene.2009.14 · Cited by 19
Why can Sensitization by a HLA-DR2 Mismatch lead to Antibodies that react also with HLA-DR1?
Marrari, M., & Duquesnoy, R. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.03.005 · Cited by 17
Basturk, A., Artan, R., & Yılmaz, A. (2017) · Gastroenterology Review · doi:10.5114/pg.2017.72099 · Cited by 16
“During the interpretation of the HLA-DQ2 and HLA-DQ8 allele levels, the detection of 0201 and 0202 for HLA-DQ2 B1 and the detection of 0302 for HLA-DQ8 B1 are regarded as positive [10].”
BackgroundLundgren, H., Martinsson, K., Cederbrant, K., Jirholt, J., Mucs, D., Madeyski-Bengtson, K., Havarinasab, S., & Hultman, P. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184744 · Cited by 17
van Heemst, J., Huizinga, T., van der Woude, D., & Toes, R. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000165 · Cited by 15
“Figure 1a schematically depicts the variation in the HLA-DR b1 domain per amino acid of the top 15 most prevalent HLA-DRB1 chains present in the Caucasian population (together covering 91% of the variations in Caucasians [21]).”
BackgroundGlišić, S., & Jailwala, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036040 · Cited by 17
“[35].”
Deitiker, P., Oshima, M., Jankovic, J., Duane, D., Aoki, K., & Atassi, M. (2011) · Autoimmunity · doi:10.3109/08916934.2010.509121 · Cited by 15
Immunogenetic Correlates of Neisseria gonorrhoeae Infection in Adolescents
Geisler, W., Wang, C., Tang, J.-M., Wilson, C. M., Crowley-Nowick, P., & Kaslow, R. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31816b6593 · Cited by 15
Mapping MHC-resident transplantation determinants.
Malkki, M., Gooley, T., Horowitz, M., Absi, L., Christiansen, F., Cornelissen, J., Dormoy, A., Dubois, V., Gagne, K., Gluckman, E., et al. (2007) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2007.05.007 · Cited by 15
Self-citationmicroRNAs: Novel Markers in Diagnostics and Therapeutics of Celiac Disease
Chamani, E., Sargolzaei, J., Tavakoli, T., & Rezaei, Z. (2019) · DNA and Cell Biology · doi:10.1089/dna.2018.4561 · Cited by 13
“2 (Klitz et al. , 2003; Meresse et al. , 2009). downregulation and reduced expression concerns with miR-31-5p in children and miR-338-3p in the duodenum of adults suffering from CD. miR-21-5p upregulation is sig-nificantly involved in the regulation of the immune response in the duodenum of CD…”
Metadata
- Authors
- Klitz, W., Maiers, M., Spellman, S., Baxter‐Lowe, L. A., Schmeckpeper, B., Williams, T. M., & Fernandez‐Viña, M.
- Affiliations
- National Marrow Donor Program (US)
- University of California, San Francisco (US)
- American Red Cross (US)
- University of New Mexico Health Sciences Center (US)
- Corresponding author
- Klitz, W.
- Venue
- Tissue Antigens
- Publisher
- Wiley
- Published
- 2003-09-16
- Volume
- 62
- Issue
- 4
- Pages
- 296-307
- ISSN
- 0001-2815 (ISSN-L)
- 1399-0039
- OpenAlex
- W1976319355
- Cited by
- 179
- References
- 0
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 9 · 2023: 5 · 2022: 1 · 2021: 9 · 2020: 9 · 2019: 4 · 2018: 6 · 2017: 11 · 2016: 6 · 2015: 12 · 2014: 7 · 2013: 8 · 2012: 12
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Tissue Antigens (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- HLA haplotype frequencies, HLA-DRB1, HLA-DQA1, HLA-DQB1, haplotype inference, linkage disequilibrium, European Americans, allogeneic transplantation, rare haplotypes
- MeSH terms
- Histocompatibility Antigens Class II, Gene Frequency, Haplotypes, Histocompatibility Testing, HLA-DQ Antigens, HLA-DR Antigens, Humans, Reference Standards, HLA-A Antigens, HLA-B Antigens, White People, HLA-DRB1 Chains, HLA-DQ alpha-Chains, HLA-DQ beta-Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review